Celldex Therapeutics, Inc. (CLDX) compared with its closest peers (JSPR, ELTX, APVO, IMRX, ABSI). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Jasper Therapeutics: names this company as a competitor in its 10-K.
| Company | Market Cap | P/E |
|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | $21.96M | — |
| Elicio Therapeutics, Inc. (ELTX) | $54.40M | — |
| Aptevo Therapeutics Inc. (APVO) | $3.35M | 0.4 |
| Immuneering Corporation (IMRX) | $275.61M | — |
| Absci Corporation (ABSI) | $1.28B | — |
| Equillium, Inc. (EQ) | $134.11M | — |
| Aldeyra Therapeutics, Inc. (ALDX) | $81.13M | — |
| AN2 Therapeutics, Inc. (ANTX) | $204.34M | — |
| Seres Therapeutics, Inc. (MCRB) | $49.81M | 24.9 |
| ImageneBio, Inc. (IMA) | $56.76M | — |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
CLDX overview · CLDX earnings · CLDX financials · CLDX KPIs · CLDX documents · CLDX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.